pyrvinium has been researched along with Neoplasm Metastasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, T; Liang, X; Liao, D; Qin, G; Wang, W; Wang, X; Wang, Z; Wu, Y; Zeng, YX; Zhang, R; Zhong, L | 1 |
| Abreu, MT; Astudillo, L; Capobianco, AJ; Chen, X; Cobb, MH; Doundoulakis, T; Fei, DL; Guerra, ML; Jin, K; Kirkbride, KC; Lee, E; Li, B; Long, J; Marchetti, F; Neitzel, LR; Nguyen, DM; Orton, D; Robbins, DJ; Rodriguez-Blanco, J; Sands, LR; Shen, C; Thorne, C; Wang, Z; Zaias, J | 1 |
| Fei, X; Hu, C; Liang, S; Xu, L; Yan, N; Zhang, F; Zhang, L; Zhang, Y | 1 |
3 other study(ies) available for pyrvinium and Neoplasm Metastasis
| Article | Year |
|---|---|
Targeting the CK1α/CBX4 axis for metastasis in osteosarcoma.
Topics: Animals; Biomarkers, Tumor; Casein Kinase Ialpha; Cell Line, Tumor; Cell Movement; Core Binding Factor Alpha 1 Subunit; Gene Expression; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HEK293 Cells; Humans; Ligases; Mice; Mutation; Neoplasm Metastasis; Osteosarcoma; p300-CBP Transcription Factors; Phosphorylation; Polycomb-Group Proteins; Promoter Regions, Genetic; Pyrvinium Compounds; Survival Analysis; Tumor Necrosis Factor-alpha; Ubiquitin-Protein Ligases; Ubiquitination | 2020 |
Differential abundance of CK1α provides selectivity for pharmacological CK1α activators to target WNT-dependent tumors.
Topics: Animals; Antineoplastic Agents; Benzoates; Casein Kinase Ialpha; Enzyme Activation; Enzyme Activators; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neoplasm Metastasis; Neoplasms; Organ Culture Techniques; Phosphorylation; Pyrvinium Compounds; Signal Transduction; Surface Plasmon Resonance; Wnt Proteins; Wnt Signaling Pathway; Xenograft Model Antitumor Assays; Xenopus laevis | 2017 |
WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; CD24 Antigen; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; Humans; Hyaluronan Receptors; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Neoplastic Stem Cells; Polymerase Chain Reaction; Pyrvinium Compounds; Wnt Signaling Pathway | 2016 |